An automated and high-throughput data processing workflow for PFAS identification in biota by direct infusion ultra-high resolution mass spectrometry.
Silvia DudášováJohann WurzUrs BergerThorsten ReemtsmaQiuguo FuOliver Jens LechtenfeldPublished in: Analytical and bioanalytical chemistry (2024)
The increasing recognition of the health impacts from human exposure to per- and polyfluorinated alkyl substances (PFAS) has surged the need for sophisticated analytical techniques and advanced data analyses, especially for assessing exposure by food of animal origin. Despite the existence of nearly 15,000 PFAS listed in the CompTox chemicals dashboard by the US Environmental Protection Agency, conventional monitoring and suspect screening methods often fall short, covering only a fraction of these substances. This study introduces an innovative automated data processing workflow, named PFlow, for identifying PFAS in environmental samples using direct infusion Fourier transform ion cyclotron resonance mass spectrometry (DI-FT-ICR MS). PFlow's validation on a bream liver sample, representative of low-concentration biota, involves data pre-processing, annotation of PFAS based on their precursor masses, and verification through isotopologues. Notably, PFlow annotated 17 PFAS absent in the comprehensive targeted approach and tentatively identified an additional 53 compounds, thereby demonstrating its efficiency in enhancing PFAS detection coverage. From an initial dataset of 30,332 distinct m/z values, PFlow thoroughly narrowed down the candidates to 84 potential PFAS compounds, utilizing precise mass measurements and chemical logic criteria, underscoring its potential in advancing our understanding of PFAS prevalence and of human exposure.
Keyphrases
- electronic health record
- mass spectrometry
- high throughput
- liquid chromatography
- endothelial cells
- high resolution mass spectrometry
- human health
- big data
- public health
- low dose
- drinking water
- high resolution
- machine learning
- deep learning
- ms ms
- induced pluripotent stem cells
- magnetic resonance imaging
- pluripotent stem cells
- cystic fibrosis
- drug delivery
- health information
- cross sectional
- artificial intelligence
- cancer therapy
- contrast enhanced
- simultaneous determination